Australia's largest stock trading and investment forum Australia's #1 stock forum

RGT

Click for more information

3.51%

29.5¢ argent biopharma limited

Ann: Appendix 4E and Audited 2016 Financial Report-MXC.AX, page-3

First 3 Last

Share
Profile

Follow
redgie321

1,377 Posts.

1

29/08/16

14:51

Post #: 18765798
Share

Originally posted by Luxo92 ↑

Some interesting facts coming out of this or at least nicely documented and not sure if has been mentioned previously.

The white paper with the USyd business school looks like a good off-sided benefit for all cannabis companies in Australia, giving a value to potential medical cannabis market in Australia and provides a good talking point for the industry as a whole.

The assets liabilities ratio is looking good with $8million in cash with loss previous year of $6million so we have a decent amount of money to stretch us through the next financial year. That coupled with expected revenue from the derma product lines
"The Californian distribution deal’s first-year contract is worth approximately €1.2m and the Company expects further revenue uplift in the year ahead."

Expand

The salaries of the board are a lot higher than I expected seeing as they are also flush with a tonne of stock and options.

As for the revenue (and contract you mention), i'll be much happier when it's $ in our account. Sales, as we saw before, were only sub $3k. Still can't see what that is in reference to, whether solely online store or inc. distribution deals.

Thoughts?

MXC Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MTL

Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus

AIZ

Air New Zealand ditches 2030 emissions targets – right as ASIC's Scope 3 reporting changes kick in for FY25

Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?

KSN

Mineral Hill transition kicks off for Kingston, gold and silver ramp up to follow

HIQ

HIT IQ has US patent for concussion management tech approved

There are more pages in this discussion • 31 more messages in this thread...

First 3 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 29.5¢		Change 0.010(3.51%)		Mkt cap ! $14.27M

Open	High	Low	Value	Volume
29.5¢	29.5¢	29.5¢	$1.476K	5.002K

Buyers (Bids)

No.	Vol.	Price($)
1	71	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.5¢	209	3

View Market Depth

No.	Vol.	Price($)
1	71	0.285
1	413	0.280
1	7100	0.275
2	13700	0.270
1	2000	0.260

Price($)	Vol.	No.
0.295	209	3
0.300	1000	1
0.310	5530	2
0.350	19200	1
0.370	1056	1

Last trade - 10.07am 30/07/2024 (20 minute delay)

RGT (ASX) Chart

SPONSORED BY